Shinhan Life Launches New Cancer Insurance Product Offering Health Management Services View original image


[Asia Economy Reporter Changhwan Lee] Shinhan Life announced on the 6th that it will sell the upgraded cancer insurance, ‘Shinhan Healthcare Amimyeonda Cancer Insurance (Non-dividend, Renewable).’


This product strengthens cancer coverage compared to the existing product (Shinhan Jinshim-eul Pumeun Amimyeonda Cancer Insurance) and incorporates the ‘New Life Care Service’ to allow customers to use healthcare services without additional costs both when healthy and after a cancer diagnosis.


Within a specified period and number of times, customers can receive special care services such as caregiver support, housekeeping assistance, nurse hospital accompaniment, and healthy meal delivery, as well as basic care services including health consultations, exercise and nutrition counseling, and psychological counseling from professional medical staff.


Additionally, cancer coverage is enhanced with four special riders: Surgery Rider for Specific Benign Neoplasms (including polyps) of 12 Major Organs T15 (Non-dividend, Renewable), General Cancer Diagnosis Rider T15 (Non-dividend, Renewable), General Cancer Living Expense Coverage Rider T15 (Non-dividend, Renewable), and Continuous Amimyeonda Cancer Diagnosis Rider T15 (Non-dividend, Renewable). These provide coverage from cancer prevention to living expenses during cancer treatment and diagnosis benefits in case of recurrence.


The insurance period is available in 15-year and 30-year terms, with coverage up to age 100. It is available for subscription from ages 15 to 65, with a minimum premium of 20,000 KRW.



Jae-woo Park, Executive Director of Shinhan Life, said, "This new product is cancer insurance that covers prevention, recovery after diagnosis, and also manages health. We have strengthened the necessary coverage for customers’ healthy lives."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing